Pasar al contenido principal

CONTROL TRANSCRIPCIONAL DE LA HOMEOSTASIS METABOLICA A NIVEL MULTIORGANICO POR EL FACTOR DE TIPO HOMEODOMINIO ALX3

BFU2014-52149-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Oxidative stress, altered dopamine neurotransmission and increased susceptibility to nigrostriatal neurodegeneration in diabetic mice

  • Pérez-Taboada, Iara
  • Moratalla, Rosario
  • Vallejo, Mario
Póster presentado al 6th Symposium on Biomedical Research: Advances and Perspectives in Molecular Endocrinology "In Homage to Gabriella Morreale", celebrado en el Instituto de Investigaciones Biomédicas Alberto Sols (IIBM-CSIC) el 31 de mayo de 2019., Diabetes has been associated with increased risk of neurodegenerative diseases in a number of epidemiological studies, but the underlying mechanisms are unknown. In the case of Parkinson’s disease, this association has been confirmed in an increasing number of reports, although other fail to find a link. Here, using a mouse model of diabetes, we describe oxidative stress and neurotransmission alterations in the nigrostriatal system, and investigate whether diabetes increases the vulnerability of substantia nigra neurons to neurodegeneration. We used C57BL/6 mice rendered diabetic by streptozocin injections. Dopaminergic neuron and oxidative stress markers were determined by RT-qPCR or western blot. Striatal neurotransmitter and related metabolite levels were monitored by HPLC. Oxidative stress in the striatum was determined using commercial tests. [3H]-Dopamine uptake was assessed using striatal synaptosomes. After unilateral striatal injections of a sub-threshold dose of 6OHDA, motor performance was assessed using standard tests and neurodegenerative damage was histologically studied. The expression of genes involved in the regulation of the defense response against oxidative stress, including Nrf2, Keap1, Foxo1, catalase and SOD2 was altered in the substantia nigra of diabetic mice. SOD2 protein levels were unaffected, but catalase levels and activity were reduced. Oxidative stress was confirmed by elevated 4-HNE in the striatum. Diabetes resulted in decreased levels of dopamine and their metabolites in the striatum, without affecting those of noradrenaline or serotonine. Functional changes in neurotransmission were documented by reduced levels of the dopamine transporter DAT, the potassium channel Girk2, and the presynaptic vesicle markers VMAT2 and Syb2. However, dopamine reuptake was not significantly affected in diabetic animals. Finally, histological and motor performance tests revealed increased damage and motor impairment after 6OHDA injections in diabetic mice. Our data indicate that diabetic mice develop striatal oxidative stress and present altered striatal dopaminergic neurotransmission as well as increased vulnerability of nigrostriatal neurons to neurodegenerative damage, providing new insights into the pathophysiology of a possible relationship between diabetes and Parkinson’s disease., BFU2014-52149-R and BFU2017-89336-R to M.V.; SAF2016-78207-R and PCIN-2015-098 to R.M; FPU 14/04457 to I.P.T., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Alx3 deficiency in the hypothalamic arcuate nucleus alters adipose tissue distribution, feeding and body mass composition

  • Mirasierra, Mercedes
  • Fernández-Pérez, Antonio
  • Vallejo, Mario
Póster presentado al 6th Symposium on Biomedical Research: Advances and Perspectives in Molecular Endocrinology "In Homage to Gabriella Morreale", celebrado en el Instituto de Investigaciones Biomédicas Alberto Sols (IIBM-CSIC) el 31 de mayo de 2019., Alx3, an aristaless-type homeodomain transcription factor expressed in pancreatic islets, regulates glucose homeostasis by stimulating the expression of the insulin gene in beta cells, or by coordinately inhibiting that of the glucagon gene in alfa cells in a glucose-dependent manner. Our previous studies demonstrated that Alx3 deficiency leads to enhanced islet cell apoptosis and mild hyperglycemia without reaching levels characteristic of overt diabetes. Independently of its pancreatic functions, we have previously reported using data from positron emission tomography and diffusionweighted magnetic resonance imaging that Alx3-deficient mice show signs of hypothalamic dysfunction. Indeed, the presence of Alx3 in neurons of the arcuate nucleus was demonstrated by immunofluorescence studies. In addition, Alx3-deficient mice exhibit decreased oxygen consumption, energy expenditure and respiratory exchange ratio. These studies strongly suggest that Alx3 may contribute to the systemic regulation of metabolic homeostasis by acting at the hypothalamic level independently of its functions in the pancreas. In the present study, we investigated whether the expression of genes regulating food intake in the arcuate nucleus of Alx3-deficient mice is altered, leading to changes in feeding and accumulation of fat. Alx3-knockout and control mice of similar age and body weight were used. Gene expression was determined by RT-qPCR in freshly microdissected blocks of hypothalamic tissue containing the arcuate nucleus. Body mass composition was analyzed by magnetic resonance imaging. Muscle function was assessed by treadmill, rotarod and strength tests. We found that Alx3-deficient mice exhibit reduced food intake but similar body weight relative to wild type animals. Expression of Alx3 in the arcuate nucleus was detected by immunofluorescence and confirmed by RT-qPCR. The expression of the orexigenic genes Npy and Agrp in response to fasting was similar in wild type and Alx3-deficient mice, but the expression of the anorexigenic genes Pomc and Cart was altered. Fasting and refeeding experiments showed that, after an overnight fasting, Alx3-deficient mice stopped eating shortly after the onset of the refeeding period. This coincided with elevated expression of Cart in the arcuate nucleus. Afterwards, Alx3-decicient animals proceeded to eat at a lower rate than controls. We found no differences in the hypothalamic expression of leptin, ghrelin and erythropoietin receptors. The expression of the alfaMSH receptor MC4R was similar in Alx3-mutant and in control mice, but the expression of MC3R was increased in Alx3-deficient animals. Relative to body weight, Alx3-deficient animals showed increased proportion of fat mass and reduced proportion of lean mass, as assessed by magnetic resonance imaging. In consonance with these results, muscle function (motor coordination and strength) was reduced in mutant mice relative to controls. Our results indicate that Alx3 in the arcuate nucleus of the hypothalamus regulates food intake and body mass composition., Funded by MINECO (BFU2011-24245 (BFU2014-52149-R and BFU2017-89336-R) and CIBERDEM., Peer reviewed